Your browser doesn't support javascript.
loading
Platelet function and filamin A expression in two families with novel FLNA gene mutations associated with periventricular nodular heterotopia and panlobular emphysema.
Tanner, Laura M; Kunishima, Shinji; Lehtinen, Elina; Helin, Tuukka; Volmonen, Kirsi; Lassila, Riitta; Pöyhönen, Minna.
Afiliación
  • Tanner LM; HUSLAB Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.
  • Kunishima S; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
  • Lehtinen E; Department of Medical Technology, Gifu University of Medical Science, Gifu, Japan.
  • Helin T; Coagulation Disorders Unit, Helsinki University Hospital, Research Program Unit in Systems Oncology, University of Helsinki, Helsinki, Finland.
  • Volmonen K; HUSLAB Department of Chemistry and Microbiology, Helsinki University Hospital, Helsinki, Finland.
  • Lassila R; HUS Medical Imaging Center, Helsinki University Hospital, Helsinki, Finland.
  • Pöyhönen M; Coagulation Disorders Unit, Helsinki University Hospital, Research Program Unit in Systems Oncology, University of Helsinki, Helsinki, Finland.
Am J Med Genet A ; 188(6): 1716-1722, 2022 06.
Article en En | MEDLINE | ID: mdl-35156755
Pathogenic variants of the X-linked FLNA gene encoding filamin A protein have been associated with a wide spectrum of symptoms, including the recently described pulmonary phenotype with childhood-onset panlobular emphysema. We describe three female patients from two families with novel heterozygous FLNA variants c.5837_2del and c.508C > T. Analysis of immunofluorescence of peripheral blood smears and platelet function was performed for all patients. FLNA-negative platelets were observed, suggesting that these variants result in the loss of a functional protein product. All three patients also had periventricular nodular heterotopia and panlobular emphysema. However, they had considerably milder symptoms and later age of onset than in the previously reported cases. Therefore, patients with pathogenic FLNA variants should be studied actively for lung involvement even in the absence of pronounced respiratory symptoms. Conversely, any patient with unexplained panlobular emphysema should be analyzed for pathogenic FLNA variants. We also suggest that immunofluorescence analysis is a useful tool for investigating the pathogenicity of novel FLNA variants.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfisema Pulmonar / Heterotopia Nodular Periventricular Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Child / Female / Humans Idioma: En Revista: Am J Med Genet A Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfisema Pulmonar / Heterotopia Nodular Periventricular Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Child / Female / Humans Idioma: En Revista: Am J Med Genet A Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Estados Unidos